from Wiktionary, Creative Commons Attribution/Share-Alike License

  • adj. Relating to theranostics


Sorry, no etymologies found.


  • A theranostic is a combined diagnostic and therapeutic tool.

    The Globe and Mail - Home RSS feed

  • We are, however, in the advanced stages of developing what's called a theranostic treatment for sepsis.

    The Globe and Mail - Home RSS feed

  • A theranostic is a diagnostic test that helps clinicians make the right therapeutic decision for the right patients, enabling a more personalized approach to medicine. bioMérieux is partnering with pharmaceutical companies, biotech companies and payers to develop theranostic tests which: Aktuelle Nachrichten

  • With the design of 'theranostic' molecules, mNPs could play a crucial role in developing one-stop tools to simultaneously diagnose, monitor and treat a wide range of common diseases and injuries. - latest science and technology news stories

  • Our sepsis theranostic consists of the world's first diagnostic tool for detecting endotoxin in the blood stream, called the Endotoxin Activity Assay already Health Canada and FDA approved, and owned by Spectral, and a therapeutic tool called the Toraymyxin column, which removes endotoxin from the blood.

    The Globe and Mail - Home RSS feed

  • Examples include multifunctional nanoparticles that are designed for multimodality imaging and simultaneous diagnostic and therapy theranostic applications.

  • "The need for more precise, personalized healthcare provided by our innovative diagnostic, prognostic and theranostic technologies is undeniable.



Log in or sign up to get involved in the conversation. It's quick and easy.

  • Theranostics takes advantage of novel nanotechnology platforms by incorporating therapy, imaging diagnostics, and cell targeting into one system with multifunctional capabilities. Theranostic nanomedicine exploits the multifunctional capabilities of nanoscale devices and the molecular knowledge of the human body to diagnose, treat, and possibly, prevent diseases.
    Fabrice Jotterand & Archie A. Alexander, Managing the “Known Unknowns”: Theranostic Cancer Nanomedicine and Informed Consent, in Sarah J. Hurst, ed., Biomedical Nanotechnology: Methods and Protocols (New York: Humana Press, 2011), p. 414

    May 24, 2018